abstract |
The present invention relates generally to methods for treating fibrotic diseases, and more particularly to inhibitors of CSF1-R activity for the treatment and / or prevention of fibrotic diseases, where the inhibitor is a small chemical entity (NCE). A nucleic acid or antibody or a functionally active fragment or derivative thereof. The invention further relates to the use of an inhibitor of CSF-1R activity for the manufacture of a medicament for the treatment and / or prevention of fibrotic diseases. |